Schizophrenia Support Forum
LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program
Medications
everhopeful
January 26, 2026, 1:17pm
1
2 Likes
Related topics
Topic
Replies
Views
Activity
Phase 2 Trial of LB-102 for Schizophrenia Shows Positive Impact on Cognitive Performance
News on schizophrenia and mental health matters
0
49
March 29, 2026
Best bipolar depression med
Medications
8
76
January 29, 2026
PDE10A Inhibition in Schizophrenia: A Randomised, Placebo-Controlled Phase 2
Medications
0
25
July 31, 2026
Tazbentetol for Schizophrenia Shows Symptom Improvement in Phase 2 Trial
Medications
7
106
March 28, 2026
Alto Neuroscience Announces Completion of Enrollment in Phase 2
News on schizophrenia and mental health matters
0
43
February 14, 2026